TissGeneSummary for RGSL1 |
Gene summary |
Basic gene information | Gene symbol | RGSL1 |
Gene name | regulator of G-protein signaling like 1 | |
Synonyms | RGSL|RGSL2 | |
Cytomap | UCSC genome browser: 1q25 | |
Type of gene | protein-coding | |
RefGenes | NM_032267.2, NM_181572.2,NM_001137669.1, | |
Description | regulator of G-protein signaling like 2regulator of G-protein signaling protein-like | |
Modification date | 20141207 | |
dbXrefs | MIM : 611012 | |
HGNC : HGNC | ||
Ensembl : ENSG00000121446 | ||
HPRD : 17971 | ||
Vega : OTTHUMG00000035217 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_RGSL1 | |
BioGPS: 353299 | ||
Pathway | NCI Pathway Interaction Database: RGSL1 | |
KEGG: RGSL1 | ||
REACTOME: RGSL1 | ||
Pathway Commons: RGSL1 | ||
Context | iHOP: RGSL1 | |
ligand binding site mutation search in PubMed: RGSL1 | ||
UCL Cancer Institute: RGSL1 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of RGSL1 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for RGSL1 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for RGSL1 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for RGSL1 |
TissGeneSNV for RGSL1 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.V222I | BRCA | 2 |
p.P940H | BRCA | 1 |
p.F884L | READ | 1 |
p.A378V | ESCA | 1 |
p.L342P | LIHC | 1 |
p.M725L | ACC | 1 |
p.V895I | LIHC | 1 |
p.A59T | UCEC | 1 |
p.C239G | COAD | 1 |
p.E396D | UCEC | 1 |
p.D118N | LIHC | 1 |
p.D488Y | ESCA | 1 |
p.F513L | COAD | 1 |
p.Y127F | BRCA | 1 |
p.Q1042H | UCEC | 1 |
p.D405N | ESCA | 1 |
p.V960I | BRCA | 1 |
p.L487I | UCEC | 1 |
p.A274S | ESCA | 1 |
p.I361F | LIHC | 1 |
p.R304I | UCEC | 1 |
p.E518D | COAD | 1 |
p.S129P | ESCA | 1 |
p.T735M | ACC | 1 |
p.A853T | KICH | 1 |
p.L295M | LUAD | 1 |
p.P74T | COAD | 1 |
p.F701L | UCEC | 1 |
p.L635R | UCEC | 1 |
p.E490* | UCEC | 1 |
p.E173G | LIHC | 1 |
p.E541* | LIHC | 1 |
p.F702I | THYM | 1 |
p.D273Y | LIHC | 1 |
p.S300* | ACC | 1 |
p.R666W | SARC | 1 |
p.E541X | LIHC | 1 |
p.L388P | UCEC | 1 |
p.H209Y | UCEC | 1 |
p.I683V | SARC | 1 |
p.Q1051* | CESC | 1 |
p.V569E | SARC | 1 |
p.L521I | UCEC | 1 |
p.E709X | COAD | 1 |
p.R623C | COAD | 1 |
p.V349A | UCEC | 1 |
p.E721* | UCEC | 1 |
p.R637M | UCEC | 1 |
p.E613D | COAD | 1 |
p.V895F | COAD | 1 |
p.R978S | KIRP | 1 |
p.W748G | LIHC | 1 |
p.E564A | LIHC | 1 |
p.E909K | ESCA | 1 |
p.V971A | UCEC | 1 |
p.E1075Q | ACC | 1 |
p.I683V | ACC | 1 |
Top |
TissGeneCNV for RGSL1 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for RGSL1 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for RGSL1 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for RGSL1 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for RGSL1 |
TissGeneDrug for RGSL1 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for RGSL1 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0006142 | Malignant neoplasm of breast | 2 | BeFree |
umls:C0678222 | Breast Carcinoma | 2 | BeFree |
umls:C0002395 | Alzheimer's Disease | 1 | GAD |